Module II -  New FDA Actions

Sunday August 23, 1998 - Question 9

Which of the following statements concerning the gastric motility agent cisapride (Propulsid) are true?

A) Safety and effectiveness of cisapride in pediatric patients is well established.

B) Cisapride is eliminated from the body mostly unchanged in urine.

C) Accumulation of cisapride can result in adverse cardiovascular events.

D) Drugs that induce cytochrome P450 enzymes react adversely with cisapride.

E) Overdose of cisapride has not been associated with serious effects.
 

 

Discussion